Brown E Denise, Lee How, Scott Daniel, Cummings Greta G
From the *Faculty of Nursing, University of Alberta; and †Alberta Health Services, Edmonton, Alberta, Canada.
J ECT. 2014 Sep;30(3):195-202. doi: 10.1097/YCT.0000000000000085.
Divergent opinion surrounds the use of continuation/maintenance electroconvulsive therapy (c/mECT) as a recurrence prevention strategy in depression because of limited data on efficacy and adverse effects. In an effort to synthesize what is known about its efficacy, a systematic review of controlled studies reporting efficacy of c/mECT for the prevention of relapse or recurrence of a depressive episode in adults with unipolar major depression was conducted.
Eleven electronic databases were searched with a 3-stage screening process conducted by the author with an independent review. Quality assessments and data extractions were performed on selected studies using preselected tools.
Six studies met the inclusion criteria; these are as follows: 3 randomized controlled trials, 1 small nonrandomized controlled trial, and 2 retrospective chart reviews. All participants had undergone an index course of electroconvulsive therapy with positive effects before receiving c/mECT or control/comparison interventions. One randomized controlled trial and retrospective chart review showed no significant difference between c/mECT and control/comparison interventions; the remaining 4 studies showed a significantly superior effect of c/mECT for the prevention of recurrence of depression. Monotherapy of c/mECT was less efficacious than c/mECT in combination with antidepressant medication, as was c/mECT delivered on a schedule, which was unresponsive to early signs of recurrence.
This review suggests that c/mECT is efficacious for the prevention of relapse/recurrence of major depression and that efficacy is increased when c/mECT is provided in combination with antidepressant medication and at flexible treatment intervals, responsive to early signs of recurrence.
由于关于疗效和不良反应的数据有限,对于将延续性/维持性电休克治疗(c/mECT)作为抑郁症复发预防策略的使用存在不同意见。为了综合了解其疗效,我们对报告c/mECT预防单相重度抑郁症成年患者抑郁发作复发或再发疗效的对照研究进行了系统评价。
检索了11个电子数据库,作者进行了三阶段筛选过程并进行独立评审。使用预先选定的工具对选定的研究进行质量评估和数据提取。
6项研究符合纳入标准;具体如下:3项随机对照试验、1项小型非随机对照试验和2项回顾性病历审查。所有参与者在接受c/mECT或对照/比较干预之前都接受过具有积极效果的索引电休克治疗疗程。1项随机对照试验和回顾性病历审查显示c/mECT与对照/比较干预之间无显著差异;其余4项研究显示c/mECT在预防抑郁症复发方面具有显著优越的效果。c/mECT单一疗法的疗效低于c/mECT与抗抑郁药物联合使用,按计划进行的c/mECT对复发的早期迹象也无反应。
本综述表明,c/mECT对预防重度抑郁症的复发/再发有效,并且当c/mECT与抗抑郁药物联合使用且治疗间隔灵活、对复发的早期迹象有反应时,疗效会增强。